Jiani C Yin
Overview
Explore the profile of Jiani C Yin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Wang C, Yang C, Bao H, Li N, Huang X, et al.
Cancer Sci
. 2025 Jan;
PMID: 39797621
This study analyzed targeted sequencing data from 6530 tissue samples from patients with metastatic Chinese colorectal cancer (CRC) to identify low mutation frequency and subgroup-specific driver genes, using three algorithms...
2.
Li F, Wang Y, Ping X, Yin J, Wang F, Zhang X, et al.
J Biomed Res
. 2024 Sep;
:1-16.
PMID: 39314047
Early screening is crucial for the prevention of intestinal-type gastric cancer. The objective of the current study was to ascertain molecular evolution of intestinal-type gastric cancer according to the Correa...
3.
Wang H, Lin L, Liang C, Pang J, Yin J, Zhang J, et al.
JCO Precis Oncol
. 2024 Aug;
8:e2300520.
PMID: 39102631
Purpose: Next-generation sequencing (NGS) has enabled the detection of concomitant driver alterations in non-small cell lung cancer (NSCLC). However, the magnitude and clinical relevance of concomitant drivers remain to be...
4.
Zhang Y, Wang X, Zhu Y, Liang C, Zhao L, Meng Q, et al.
Front Oncol
. 2023 Sep;
13:1222873.
PMID: 37746257
Germline variations in the DNA polymerase genes, and , can lead to a hereditary cancer syndrome that is characterized by frequent gastrointestinal polyposis and multiple primary malignant tumors. However, because...
5.
Shao X, Yin J, Wang D, Huang E, Zhang Y, Yin J, et al.
Front Oncol
. 2023 Jul;
13:1195837.
PMID: 37496667
Synchronous multiple gastric carcinoma (SMGC) is a rare condition characterized by the simultaneous occurrence of two or more primary malignant tumors in the stomach, each with its own distinct pathological...
6.
Yang X, Pi C, Zhang Y, Chen Z, Zhang X, Zhu D, et al.
Mol Carcinog
. 2023 Apr;
62(7):1001-1008.
PMID: 37067398
Mutations in epidermal growth factor receptor and anaplastic lymphoma kinase are common driver events in non-small cell lung cancer (NSCLC), which are associated with a high frequency of bone metastases...
7.
Zhao W, Song A, Xu Y, Wu Q, Liu C, Yin J, et al.
BMC Med
. 2023 Feb;
21(1):73.
PMID: 36829178
Background: Compound epidermal growth factor receptor (EGFR) mutations are less responsive to tyrosine kinase inhibitors (TKIs) than single EGFR mutations in non-small cell lung cancer (NSCLC). However, the detailed clinical...
8.
Huang R, Shen G, Ren Y, Zheng K, Wang J, Shi Y, et al.
J Transl Med
. 2023 Feb;
21(1):78.
PMID: 36739402
Background: Acral melanoma (AM) is the most common subtype in Chinese melanoma patients with a very poor prognosis. However, our understanding of the disease pathogenesis and molecular landscape is limited...
9.
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis
Gao W, Wu L, Jin S, Li J, Liu X, Xu J, et al.
J Immunother Cancer
. 2022 Nov;
10(11).
PMID: 36450378
The mechanism(s) of immune checkpoint inhibitor (ICI)-induced myasthenia gravis (MG), an immune-related adverse event (irAE) that is fatal and limits subsequent ICI use, remain unexplored. Here, through comparative genomic analysis,...
10.
Li Y, Xie Y, Wang D, Xu H, Ye J, Yin J, et al.
Front Oncol
. 2022 Nov;
12:963364.
PMID: 36387164
Background: Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like (LFL) syndrome are rare hereditary diseases characterized by predisposition to a diverse spectrum of cancer types, primarily sarcoma. The pathogenic variants underlying the majority...